Genentech Inc. and Singularity University, a Mountain View institution focused on advancing technology, forged a deal aimed at the future of medicine.
South San Francisco-based Genentech will support Singularity University’s annual Summer Graduate Studies Program, a 10-week session blending various scientific and technology disciplines and become a leading sponsor of the institution’s 2012 FutureMed Program.
That event, which started Monday, runs through Saturday at Singularity University’s campus at NASA Research Park.
Financial terms of the deal were not disclosed.
After similar deals over the past couple of years with the likes of Autodesk (NASDAQ: ADSK), Cisco (NASDAQ: CSCO), Google (NASDAQ: GOOG), and the Kauffman Foundation, the Genentech pact represents Singularity’s first large-scale biotech partnership, said CEO Rob Nail.
“It’s a tremendous opportunity to be partnered with a company so committed to cutting-edge science, innovation and improving medicine and health care,” Nail said in a press release Monday.